Nurix Therapeutics NRIX
NASDAQ NRIX
$16.32 +0.44 (+2.77%)
As of: Nov 11, 2026 · 3:59 PM EST

Nurix Therapeutics (NRIX) Change in Receivables (2023 - 2026)

Updated

Nurix Therapeutics (NRIX) reported Change in Receivables of $20 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), compared with -$19 million a year earlier.

Analysis

Nurix Therapeutics (NRIX) Change in Receivables (2023 - 2026) Analysis & Trends

Over the twelve months ended Aug 31, 2026, Nurix Therapeutics' Change in Receivables came in at $1 million; for FY2022 (ended Nov 30, 2022), it was -$6 million.

  • By fiscal year, Change in Receivables came in at $6 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -188.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -312.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 108.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -52.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Nurix Therapeutics 1.73 Bn -891.35 Mn - 20.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 20.00 Mn
Aug 31, 2025 -19.00 Mn
Nov 30, 2023 -2.00 Mn
Aug 31, 2023 2.00 Mn
API Access

Nurix Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=NRIX&period=max&api_key=YOUR_API_KEY